Status:
COMPLETED
Transcutaneous Bilirubinometers in the Community
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Women and Children's Health Research Institute, Canada
Capital Health, Canada
Conditions:
Jaundice, Neonatal
Eligibility:
All Genders
24-2 years
Phase:
NA
Brief Summary
Jaundice is the most frequent reason for readmission for healthy newborns after discharge from the nursery. In the Capital Health area, around 2.5% (315 babies in 2005) of all healthy newborns were ad...
Eligibility Criteria
Inclusion
- All near term (35 and 36 weeks gestational age) and term (37 to 41 weeks) babies living in Alberta Capital Health (CH) region
- Born at any Capital Health or Caritas delivery facility(Royal Alexandra Hospital, Grey Nuns Community Hospital, Misericordia Community Hospital, Sturgeon Community Hospital, Fort Saskatchewan Health Centre, and WestView Health Centre)
- Discharged home from the nursery within 96 hours of life
Exclusion
- Babies who do not live in CH region
- Babies born at less than 35 weeks gestational age
- Babies initially admitted to a Special Care Nursery (SCN) or a Neonatal Intensive Care unit (NICU) for more than 72 hours
- Babies born to opting-out mothers will also be excluded
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT00735319
Start Date
September 1 2008
End Date
December 1 2009
Last Update
January 12 2010
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Alexandra Hospital
Edmonton, Alberta, Canada, T5H 3V9
2
Misericordia Community Hospital
Edmonton, Alberta, Canada, T5R 4H5
3
Grey Nuns Community Hospital
Edmonton, Alberta, Canada, T6L 5X8
4
Sturgeon Community Hospital
Edmonton, Alberta, Canada, T8N 6C4